Form 8-K - Current report:
SEC Accession No. 0001641172-25-009967
Filing Date
2025-05-13
Accepted
2025-05-13 16:29:36
Documents
13
Period of Report
2025-05-13
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 88411
  Complete submission text file 0001641172-25-009967.txt   262500

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rgbp-20250513.xsd EX-101.SCH 3041
3 XBRL LABEL FILE rgbp-20250513_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE rgbp-20250513_pre.xml EX-101.PRE 22376
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3457
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-722-5505
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

EIN.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 25940606
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)